CIP
Champlain Investment Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-256,730
| Closed | -$97.3M | – | 127 |
|
|
2023
Q2 | $97.3M | Buy |
256,730
+39,065
| +18% | +$14.8M | 0.6% | 72 |
|
|
2023
Q1 | $104M | Sell |
217,665
-1,060
| -0.5% | -$508K | 0.66% | 64 |
|
|
2022
Q4 | $92M | Sell |
218,725
-4,965
| -2% | -$2.09M | 0.59% | 75 |
|
|
2022
Q3 | $93.3M | Sell |
223,690
-4,820
| -2% | -$2.01M | 0.64% | 69 |
|
|
2022
Q2 | $113M | Sell |
228,510
-15,995
| -7% | -$7.92M | 0.73% | 59 |
|
|
2022
Q1 | $138M | Sell |
244,505
-270
| -0.1% | -$152K | 0.71% | 62 |
|
|
2021
Q4 | $185M | Sell |
244,775
-6,000
| -2% | -$4.53M | 0.84% | 46 |
|
|
2021
Q3 | $187M | Sell |
250,775
-10,540
| -4% | -$7.86M | 0.9% | 40 |
|
|
2021
Q2 | $168M | Buy |
261,315
+1,915
| +0.7% | +$1.23M | 0.8% | 50 |
|
|
2021
Q1 | $148M | Buy |
259,400
+26,155
| +11% | +$14.9M | 0.77% | 54 |
|
|
2020
Q4 | $136M | Buy |
233,245
+25,375
| +12% | +$14.8M | 0.78% | 56 |
|
|
2020
Q3 | $107M | Buy |
207,870
+5,720
| +3% | +$2.95M | 0.73% | 60 |
|
|
2020
Q2 | $91.3M | Buy |
202,150
+99,425
| +97% | +$44.9M | 0.66% | 60 |
|
|
2020
Q1 | $36M | Buy |
+102,725
| New | +$36M | 0.32% | 98 |
|
|
2015
Q1 | – | Sell |
-108,830
| Closed | -$13.1M | – | 132 |
|
|
2014
Q4 | $13.1M | Sell |
108,830
-593,695
| -85% | -$71.6M | 0.21% | 115 |
|
|
2014
Q3 | $79.7M | Sell |
702,525
-123,630
| -15% | -$14M | 1.38% | 12 |
|
|
2014
Q2 | $98.9M | Buy |
826,155
+26,345
| +3% | +$3.15M | 1.62% | 10 |
|
|
2014
Q1 | $102M | Buy |
799,810
+17,415
| +2% | +$2.23M | 1.76% | 7 |
|
|
2013
Q4 | $96.7M | Sell |
782,395
-1,735
| -0.2% | -$214K | 1.7% | 8 |
|
|
2013
Q3 | $92.2M | Buy |
784,130
+42,835
| +6% | +$5.04M | 1.75% | 4 |
|
|
2013
Q2 | $83.2M | Buy |
+741,295
| New | +$83.2M | 1.68% | 5 |
|